Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 638

1.

Clinical characteristics and outcomes of relapsed follicular lymphoma after autologous stem cell transplantation in the rituximab era.

Sesques P, Bourcier J, Golfier C, Lebras L, Nicolas-Virelizier E, Hacini M, Perrin MC, Voillat L, Bachy E, Traverse-Glehen A, Moreau A, Martin L, Ramla S, Casasnovas O, Le Gouill S, Salles G, Ghesquières H.

Hematol Oncol. 2020 Jan 18. doi: 10.1002/hon.2713. [Epub ahead of print]

PMID:
31953963
2.

Pixantrone plus rituximab versus gemcitabine plus rituximab in patients with relapsed aggressive B-cell non-Hodgkin lymphoma not eligible for stem cell transplantation: a phase 3, randomized, multicentre trial (PIX306).

Pettengell R, Długosz-Danecka M, Andorsky D, Belada D, Georgiev P, Quick D, Singer JW, Singh SB, Pallis A, Egorov A, Salles G.

Br J Haematol. 2020 Jan;188(2):240-248. doi: 10.1111/bjh.16255. Epub 2019 Dec 27.

PMID:
31879945
3.

Long-term follow-up of patients with mantle cell lymphoma (MCL) treated with the selective Bruton's tyrosine kinase inhibitor tirabrutinib (GS/ONO-4059).

Rule SA, Cartron G, Fegan C, Morschhauser F, Han L, Mitra S, Salles G, Dyer MJS.

Leukemia. 2019 Dec 11. doi: 10.1038/s41375-019-0658-7. [Epub ahead of print] No abstract available.

PMID:
31827243
4.

Treatment of Older Patients With Mantle Cell Lymphoma (MCL): Long-Term Follow-Up of the Randomized European MCL Elderly Trial.

Kluin-Nelemans HC, Hoster E, Hermine O, Walewski J, Geisler CH, Trneny M, Stilgenbauer S, Kaiser F, Doorduijn JK, Salles G, Szymczyk M, Tilly H, Kanz L, Schmidt C, Feugier P, Thieblemont C, Zijlstra JM, Ribrag V, Klapper W, Pott C, Unterhalt M, Dreyling MH.

J Clin Oncol. 2020 Jan 20;38(3):248-256. doi: 10.1200/JCO.19.01294. Epub 2019 Dec 5.

PMID:
31804876
5.

Reply to S. Fuji.

Bachy E, Salles G.

J Clin Oncol. 2019 Dec 5:JCO1902689. doi: 10.1200/JCO.19.02689. [Epub ahead of print] No abstract available.

PMID:
31804865
6.

Reply to Drs Mantovani and Zusi.

Villela-Nogueira CA, Leite NC, Machado CM, Cardoso CR, Salles GF.

Nutr Metab Cardiovasc Dis. 2020 Jan 3;30(1):164-166. doi: 10.1016/j.numecd.2019.09.010. Epub 2019 Sep 21. No abstract available.

PMID:
31753786
7.

Single-agent ibrutinib in RESONATE-2™ and RESONATE™ versus treatments in the real-world PHEDRA databases for patients with chronic lymphocytic leukemia.

Salles G, Bachy E, Smolej L, Simkovic M, Baseggio L, Panovska A, Besson H, Healy N, Garside J, Iraqi W, Diels J, Pick-Lauer C, Spacek M, Urbanova R, Lysak D, Hermans R, Lundbom J, Callet-Bauchu E, Doubek M.

Ann Hematol. 2019 Dec;98(12):2749-2760. doi: 10.1007/s00277-019-03830-8. Epub 2019 Nov 19.

8.

The Need for a Consensus Next-generation Sequencing Panel for Mature Lymphoid Malignancies.

Sujobert P, Le Bris Y, de Leval L, Gros A, Merlio JP, Pastoret C, Huet S, Sarkozy C, Davi F, Callanan M, Thieblemont C, Sibon D, Asnafi V, Preudhomme C, Gaulard P, Jardin F, Salles G, Macintyre E.

Hemasphere. 2018 Dec 27;3(1):e169. doi: 10.1097/HS9.0000000000000169. eCollection 2019 Feb.

9.

New Treatment Options in Advanced Stage Follicular Lymphoma.

Hübel K, Salles G, Marcus R, Zinzani PL, Dreyling M.

Hemasphere. 2018 Nov 28;2(6):e156. doi: 10.1097/HS9.0000000000000156. eCollection 2018 Dec. Review.

10.

Refining diffuse large B-cell lymphoma subgroups using integrated analysis of molecular profiles.

Dubois S, Tesson B, Mareschal S, Viailly PJ, Bohers E, Ruminy P, Etancelin P, Peyrouze P, Copie-Bergman C, Fabiani B, Petrella T, Jais JP, Haioun C, Salles G, Molina TJ, Leroy K, Tilly H, Jardin F; Lymphoma Study Association (LYSA) investigators.

EBioMedicine. 2019 Oct;48:58-69. doi: 10.1016/j.ebiom.2019.09.034. Epub 2019 Oct 21.

11.

Neuroprotective and restorative properties of the GLP-1/GIP dual agonist DA-JC1 compared with a GLP-1 single agonist in Alzheimer's disease.

Salles GN, Calió ML, Hölscher C, Pacheco-Soares C, Porcionatto M, Lobo AO.

Neuropharmacology. 2020 Jan 1;162:107813. doi: 10.1016/j.neuropharm.2019.107813. Epub 2019 Oct 16.

PMID:
31628935
12.

Metagenomic Investigation of Torque Teno Mini Virus-SH in Hematological Patients.

Bal A, Oriol G, Josset L, Generenaz L, Sarkozy C, Sesques P, Salles G, Morfin F, Lina B, Becker J, Reynier F, Mallet F, Pachot A, Cheynet V, Brengel-Pesce K, Trouillet-Assant S.

Front Microbiol. 2019 Sep 18;10:1898. doi: 10.3389/fmicb.2019.01898. eCollection 2019.

13.

On-Target Pharmacodynamic Activity of the PI3K Inhibitor Copanlisib in Paired Biopsies from Patients with Malignant Lymphoma and Advanced Solid Tumors.

Morschhauser F, Machiels JP, Salles G, Rottey S, Rule SA, Cunningham D, Peyrade F, Fruchart C, Arkenau HT, Genvresse I, Liu L, Köchert K, Shen K, Kneip C, Peña CE, Grevel J, Zhang J, Cisternas G, Reschke S, Granvil C, Awada A.

Mol Cancer Ther. 2019 Oct 16. pii: molcanther.0466.2019. doi: 10.1158/1535-7163.MCT-19-0466. [Epub ahead of print]

PMID:
31619463
14.

Prognostic Importance of Resistant Hypertension in Patients With Type 2 Diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study.

Cardoso CRL, Leite NC, Bacan G, Ataíde DS, Gorgonio LKC, Salles GF.

Diabetes Care. 2020 Jan;43(1):219-227. doi: 10.2337/dc19-1534. Epub 2019 Oct 16.

PMID:
31619394
15.

Pembrolizumab in Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma.

Armand P, Rodig S, Melnichenko V, Thieblemont C, Bouabdallah K, Tumyan G, Özcan M, Portino S, Fogliatto L, Caballero MD, Walewski J, Gulbas Z, Ribrag V, Christian B, Perini GF, Salles G, Svoboda J, Zain J, Patel S, Chen PH, Ligon AH, Ouyang J, Neuberg D, Redd R, Chatterjee A, Balakumaran A, Orlowski R, Shipp M, Zinzani PL.

J Clin Oncol. 2019 Dec 1;37(34):3291-3299. doi: 10.1200/JCO.19.01389. Epub 2019 Oct 14.

PMID:
31609651
16.

Inherited variants at 3q13.33 and 3p24.1 are associated with risk of diffuse large B-cell lymphoma and implicate immune pathways.

Kleinstern G, Yan H, Hildebrandt MAT, Vijai J, Berndt SI, Ghesquières H, McKay J, Wang SS, Nieters A, Ye Y, Monnereau A, Brooks-Wilson AR, Lan Q, Melbye M, Jackson RD, Teras LR, Purdue MP, Vajdic CM, Vermeulen RCH, Giles GG, Cocco PL, Birmann BM, Kraft P, Albanes D, Zeleniuch-Jacquotte A, Crouch S, Zhang Y, Sarangi V, Asmann Y, Offit K, Salles G, Wu X, Smedby KE, Skibola CF, Slager SL, Rothman N, Chanock SJ, Cerhan JR.

Hum Mol Genet. 2019 Oct 10. pii: ddz228. doi: 10.1093/hmg/ddz228. [Epub ahead of print]

PMID:
31600786
17.

Unclassifiable Isolated Monoclonal Lymphocytosis: Comprehensive Description of a Retrospective Cohort.

Degaud M, Baseggio L, Grange B, Manzoni D, Huet S, Callet-Bauchu E, Traverse-Glehen A, Davi F, Ghesquières H, Salles G, Sujobert P.

Cancers (Basel). 2019 Oct 4;11(10). pii: E1495. doi: 10.3390/cancers11101495.

18.

Association between high titers of glutamic acid decarboxylase antibody and epilepsy in patients with type 1 diabetes mellitus: A cross-sectional study.

Aguiar TS, Dantas JR, Cabral DB, Rêgo CCS, Zajdenverg L, Salles GF, Alves-Leon SV, Rodacki M, Lima MA.

Seizure. 2019 Oct;71:318-321. doi: 10.1016/j.seizure.2019.09.003. Epub 2019 Sep 9.

PMID:
31525611
19.

Prognostic Significance of MYC Rearrangement and Translocation Partner in Diffuse Large B-Cell Lymphoma: A Study by the Lunenburg Lymphoma Biomarker Consortium.

Rosenwald A, Bens S, Advani R, Barrans S, Copie-Bergman C, Elsensohn MH, Natkunam Y, Calaminici M, Sander B, Baia M, Smith A, Painter D, Pham L, Zhao S, Ziepert M, Jordanova ES, Molina TJ, Kersten MJ, Kimby E, Klapper W, Raemaekers J, Schmitz N, Jardin F, Stevens WBC, Hoster E, Hagenbeek A, Gribben JG, Siebert R, Gascoyne RD, Scott DW, Gaulard P, Salles G, Burton C, de Jong D, Sehn LH, Maucort-Boulch D.

J Clin Oncol. 2019 Dec 10;37(35):3359-3368. doi: 10.1200/JCO.19.00743. Epub 2019 Sep 9.

PMID:
31498031
20.

Long-term safety and efficacy of rituximab in 248 adults with immune thrombocytopenia: Results at 5 years from the French prospective registry ITP-ritux.

Deshayes S, Khellaf M, Zarour A, Layese R, Fain O, Terriou L, Viallard JF, Cheze S, Graveleau J, Slama B, Audia S, Cliquennois M, Ebbo M, Le Guenno G, Salles G, Bonmati C, Teillet F, Galicier L, Lambotte O, Hot A, Lefrère F, Mahévas M, Canoui-Poitrine F, Michel M, Godeau B.

Am J Hematol. 2019 Dec;94(12):1314-1324. doi: 10.1002/ajh.25632. Epub 2019 Oct 8.

PMID:
31489694
21.

[Follicular lymphoma: An update].

Sujobert P, Salles G.

Presse Med. 2019 Jul - Aug;48(7-8 Pt 1):850-858. doi: 10.1016/j.lpm.2019.07.024. Epub 2019 Aug 22. Review. French.

PMID:
31447334
22.

Actualités dans les lymphomes à petites cellules non folliculaires.

Sarkozy C, Salles G.

Presse Med. 2019 Jul - Aug;48(7-8 Pt 1):859-870. doi: 10.1016/j.lpm.2019.07.025. Epub 2019 Aug 22. Review. French.

PMID:
31447331
23.

Pattern of Care and Outcomes of Adolescent and Young Adults with Lymphoma Treated in the Rhône-Alpes Region.

Dony A, Belhabri A, Bertrand Y, Sebban C, Cony-Makhoul P, Sobh M, Rogasik M, Salles G, Anglaret B, Freycon C, Corm S, Faurie P, Cornillon J, Michallet AS, Chassagne-Clément C, Berger F, Ray-Coquard IL.

J Adolesc Young Adult Oncol. 2019 Dec;8(6):684-696. doi: 10.1089/jayao.2019.0016. Epub 2019 Aug 14.

PMID:
31411521
24.

Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes.

Din L, Sheikh M, Kosaraju N, Smedby KE, Bernatsky S, Berndt SI, Skibola CF, Nieters A, Wang S, McKay JD, Cocco P, Maynadié M, Foretová L, Staines A, Mack TM, de Sanjosé S, Vyse TJ, Padyukov L, Monnereau A, Arslan AA, Moore A, Brooks-Wilson AR, Novak AJ, Glimelius B, Birmann BM, Link BK, Stewart C, Vajdic CM, Haioun C, Magnani C, Conti DV, Cox DG, Casabonne D, Albanes D, Kane E, Roman E, Muzi G, Salles G, Giles GG, Adami HO, Ghesquières H, De Vivo I, Clavel J, Cerhan JR, Spinelli JJ, Hofmann J, Vijai J, Curtin K, Costenbader KH, Onel K, Offit K, Teras LR, Morton L, Conde L, Miligi L, Melbye M, Ennas MG, Liebow M, Purdue MP, Glenn M, Southey MC, Din M, Rothman N, Camp NJ, Wong Doo N, Becker N, Pradhan N, Bracci PM, Boffetta P, Vineis P, Brennan P, Kraft P, Lan Q, Severson RK, Vermeulen RCH, Milne RL, Kaaks R, Travis RC, Weinstein SJ, Chanock SJ, Ansell SM, Slager SL, Zheng T, Zhang Y, Benavente Y, Taub Z, Madireddy L, Gourraud PA, Oksenberg JR, Cozen W, Hjalgrim H, Khankhanian P.

Genet Epidemiol. 2019 Oct;43(7):844-863. doi: 10.1002/gepi.22242. Epub 2019 Aug 13.

PMID:
31407831
25.

PNPLA3 gene polymorphism in Brazilian patients with type 2 diabetes: A prognostic marker beyond liver disease?

Machado CM, Leite NC, França PH, Cardoso CR, Salles GF, Villela-Nogueira CA.

Nutr Metab Cardiovasc Dis. 2019 Sep;29(9):965-971. doi: 10.1016/j.numecd.2019.06.002. Epub 2019 Jun 14.

PMID:
31377187
26.

Lipid peroxidation and protein oxidation in broiler breast fillets with white striping myopathy.

Salles GBC, Boiago MM, Silva AD, Morsch VM, Gris A, Mendes RE, Baldissera MD, da Silva AS.

J Food Biochem. 2019 Apr;43(4):e12792. doi: 10.1111/jfbc.12792. Epub 2019 Feb 6.

PMID:
31353592
27.

Sustained Progression-Free Survival Benefit of Rituximab Maintenance in Patients With Follicular Lymphoma: Long-Term Results of the PRIMA Study.

Bachy E, Seymour JF, Feugier P, Offner F, López-Guillermo A, Belada D, Xerri L, Catalano JV, Brice P, Lemonnier F, Martin A, Casasnovas O, Pedersen LM, Dorvaux V, Simpson D, Leppa S, Gabarre J, da Silva MG, Glaisner S, Ysebaert L, Vekhoff A, Intragumtornchai T, Le Gouill S, Lister A, Estell JA, Milone G, Sonet A, Farhi J, Zeuner H, Tilly H, Salles G.

J Clin Oncol. 2019 Nov 1;37(31):2815-2824. doi: 10.1200/JCO.19.01073. Epub 2019 Jul 24.

PMID:
31339826
28.

Obinutuzumab and ibrutinib induction therapy followed by a minimal residual disease-driven strategy in patients with chronic lymphocytic leukaemia (ICLL07 FILO): a single-arm, multicentre, phase 2 trial.

Michallet AS, Dilhuydy MS, Subtil F, Rouille V, Mahe B, Laribi K, Villemagne B, Salles G, Tournilhac O, Delmer A, Portois C, Pegourie B, Leblond V, Tomowiak C, de Guibert S, Orsini F, Banos A, Carassou P, Cartron G, Fornecker LM, Ysebaert L, Dartigeas C, Truchan Graczyk M, Vilque JP, Aurran T, Cymbalista F, Lepretre S, Lévy V, Nguyen-Khac F, Le Garff-Tavernier M, Aanei C, Ticchioni M, Letestu R, Feugier P.

Lancet Haematol. 2019 Sep;6(9):e470-e479. doi: 10.1016/S2352-3026(19)30113-9. Epub 2019 Jul 16.

PMID:
31324600
29.

Obinutuzumab combined with lenalidomide for relapsed or refractory follicular B-cell lymphoma (GALEN): a multicentre, single-arm, phase 2 study.

Morschhauser F, Le Gouill S, Feugier P, Bailly S, Nicolas-Virelizier E, Bijou F, Salles GA, Tilly H, Fruchart C, Van Eygen K, Snauwaert S, Bonnet C, Haioun C, Thieblemont C, Bouabdallah R, Wu KL, Canioni D, Meignin V, Cartron G, Houot R.

Lancet Haematol. 2019 Aug;6(8):e429-e437. doi: 10.1016/S2352-3026(19)30089-4. Epub 2019 Jul 8.

PMID:
31296423
30.

HbA1c variability and long-term glycemic control are linked to diabetic retinopathy and glomerular filtration rate in patients with type 1 diabetes and multiethnic background.

Rosa LCGFD, Zajdenverg L, Souto DL, Dantas JR, Pinto MVR, Salles GFDCM, Rodacki M.

J Diabetes Complications. 2019 Sep;33(9):610-615. doi: 10.1016/j.jdiacomp.2019.05.022. Epub 2019 May 31.

PMID:
31227288
31.

Parameters influencing the pharmacokinetics/pharmacodynamics of piperacillin/tazobactam in patients with febrile neutropenia and haematological malignancy: a prospective study.

Benech N, Dumitrescu O, Conrad A, Balsat M, Paubelle E, Ducastelle-Lepretre S, Labussière-Wallet H, Salles G, Cohen S, Goutelle S, Ader F; Lyon HEMINF Study Group .

J Antimicrob Chemother. 2019 Sep 1;74(9):2676-2680. doi: 10.1093/jac/dkz248.

PMID:
31219562
32.

Efficiency of blinatumomab in a t(8;21) acute myeloid leukemia expressing CD19.

Plesa A, Labussière-Wallet H, Hayette S, Salles G, Thomas X, Sujobert P.

Haematologica. 2019 Oct;104(10):e487-e488. doi: 10.3324/haematol.2019.225557. Epub 2019 Jun 13. No abstract available.

33.

New drugs for old targets.

Salles G.

Hematol Oncol. 2019 Jun;37 Suppl 1:101-104. doi: 10.1002/hon.2599. Review.

PMID:
31187537
34.

Rebuttal From Drs Cardoso and Salles.

Cardoso CRL, Salles GF.

Chest. 2019 Jun;155(6):1102-1103. doi: 10.1016/j.chest.2019.04.005. No abstract available.

PMID:
31174634
35.

COUNTERPOINT: Should Sleep Studies Be Performed for All Patients With Poorly Controlled Hypertension? No.

Cardoso CRL, Salles GF.

Chest. 2019 Jun;155(6):1097-1101. doi: 10.1016/j.chest.2019.04.007. No abstract available.

PMID:
31174632
36.

BAM conditioning before autologous transplantation for lymphoma: a study on behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC).

Cornillon J, Daguenet E, Bay JO, Chauchet A, Salles G, Contentin N, Nicolas-Virelizier E, Mercier M, Vallet N, Alexis M, Chrétien ML, Cluzeau T, Huynh A, Himberlin C, Dorvaux V, Amorim S, Lejeune C, de Latour RP, Gyan E.

Ann Hematol. 2019 Aug;98(8):1973-1980. doi: 10.1007/s00277-019-03704-z. Epub 2019 May 20.

PMID:
31111177
37.

Polatuzumab vedotin in combination with immunochemotherapy in patients with previously untreated diffuse large B-cell lymphoma: an open-label, non-randomised, phase 1b-2 study.

Tilly H, Morschhauser F, Bartlett NL, Mehta A, Salles G, Haioun C, Munoz J, Chen AI, Kolibaba K, Lu D, Yan M, Penuel E, Hirata J, Lee C, Sharman JP.

Lancet Oncol. 2019 Jul;20(7):998-1010. doi: 10.1016/S1470-2045(19)30091-9. Epub 2019 May 14.

PMID:
31101489
38.

Human herpesvirus 6 infection after autologous stem cell transplantation: A multicenter prospective study in adult patients.

Balsat M, Pillet S, Tavernier E, Cacheux V, Escuret V, Moluçon-Chabrot C, Augeul-Meunier K, Mirand A, Regagnon C, Tinquaut F, Bousser V, Oriol M, Guyotat D, Salles G, Bay JO, Pozzetto B, Cornillon J.

J Infect. 2019 Jul;79(1):36-42. doi: 10.1016/j.jinf.2019.05.001. Epub 2019 May 7.

PMID:
31075291
39.

Prognostic Value of Genetic Alterations in Elderly Patients with Acute Myeloid Leukemia: A Single Institution Experience.

Heiblig M, Labussière-Wallet H, Nicolini FE, Michallet M, Hayette S, Sujobert P, Plesa A, Balsat M, Paubelle E, Barraco F, Tigaud I, Ducastelle S, Wattel E, Salles G, Thomas X.

Cancers (Basel). 2019 Apr 22;11(4). pii: E570. doi: 10.3390/cancers11040570.

40.

Polatuzumab vedotin or pinatuzumab vedotin plus rituximab in patients with relapsed or refractory non-Hodgkin lymphoma: final results from a phase 2 randomised study (ROMULUS).

Morschhauser F, Flinn IW, Advani R, Sehn LH, Diefenbach C, Kolibaba K, Press OW, Salles G, Tilly H, Chen AI, Assouline S, Cheson BD, Dreyling M, Hagenbeek A, Zinzani PL, Jones S, Cheng J, Lu D, Penuel E, Hirata J, Wenger M, Chu YW, Sharman J.

Lancet Haematol. 2019 May;6(5):e254-e265. doi: 10.1016/S2352-3026(19)30026-2. Epub 2019 Mar 29.

PMID:
30935953
41.

Long-term fatigue in survivors of non-Hodgkin lymphoma: The Lymphoma Study Association SIMONAL cross-sectional study.

Mounier N, Anthony S, Busson R, Thieblemont C, Ribrag V, Tilly H, Haioun C, Casasnovas RO, Morschhauser F, Feugier P, Delarue R, Ysebaert L, Sebban C, Broussais-Guillaumot F, Damaj G, Nerich V, Jais JP, Laborde L, Salles G, Henry-Amar M.

Cancer. 2019 Mar 22. doi: 10.1002/cncr.32040. [Epub ahead of print]

PMID:
30901086
42.

Unravelling Subtleties of Angioimmunoblastic T-Cell Lymphoma.

Bachy E, Salles G.

J Oncol Pract. 2019 Mar;15(3):147-148. doi: 10.1200/JOP.19.00089. No abstract available.

PMID:
30861363
43.

Venetoclax plus R- or G-CHOP in non-Hodgkin lymphoma: results from the CAVALLI phase 1b trial.

Zelenetz AD, Salles G, Mason KD, Casulo C, Le Gouill S, Sehn LH, Tilly H, Cartron G, Chamuleau MED, Goy A, Tam CS, Lugtenburg PJ, Petrich AM, Sinha A, Samineni D, Herter S, Ingalla E, Szafer-Glusman E, Klein C, Sampath D, Kornacker M, Mobasher M, Morschhauser F.

Blood. 2019 May 2;133(18):1964-1976. doi: 10.1182/blood-2018-11-880526. Epub 2019 Mar 8.

44.

Phase 2 Study of Daratumumab in Relapsed/Refractory Mantle-Cell Lymphoma, Diffuse Large B-Cell Lymphoma, and Follicular Lymphoma.

Salles G, Gopal AK, Minnema MC, Wakamiya K, Feng H, Schecter JM, Wang M.

Clin Lymphoma Myeloma Leuk. 2019 May;19(5):275-284. doi: 10.1016/j.clml.2018.12.013. Epub 2019 Jan 2.

PMID:
30795996
45.

VaccHemInf project: protocol for a prospective cohort study of efficacy, safety and characterisation of immune functional response to vaccinations in haematopoietic stem cell transplant recipients.

Conrad A, Boccard M, Valour F, Alcazer V, Tovar Sanchez AT, Chidiac C, Laurent F, Vanhems P, Salles G, Brengel-Pesce K, Meunier B, Trouillet-Assant S, Ader F; Lyon HEMINF Study Group.

BMJ Open. 2019 Feb 15;9(2):e026093. doi: 10.1136/bmjopen-2018-026093.

46.

Treatment of aggressive B-cell non-Hodgkin lymphoma beyond frontline therapy in patients not eligible for stem cell transplantation: a structured review.

Salles GA, Pettengell R, Cordoba R, Długosz-Danecka M, Jurczak W, Tilly H.

Leuk Lymphoma. 2019 Jul;60(7):1610-1625. doi: 10.1080/10428194.2018.1564828. Epub 2019 Jan 31.

PMID:
30702000
47.

Efficacy of diacerein in reducing liver steatosis and fibrosis in patients with type 2 diabetes and non-alcoholic fatty liver disease: A randomized, placebo-controlled trial.

Leite NC, Viegas BB, Villela-Nogueira CA, Carlos FO, Cardoso CRL, Salles GF.

Diabetes Obes Metab. 2019 May;21(5):1266-1270. doi: 10.1111/dom.13643. Epub 2019 Mar 4.

PMID:
30687994
48.

L’émergence des traitements par cellules CAR-T dans les lymphomes.

Salles G, Sesques P, Ferrant E, Safar V, Ghesquieres H, Bachy E.

Bull Cancer. 2018 Dec;105 Suppl 2:S168-S177. doi: 10.1016/S0007-4551(19)30047-5. Review. French.

PMID:
30686355
49.

Early-onset severe infections in allogeneic hematopoietic stem cell transplantation recipients with graft failure.

Alcazer V, Conrad A, Valour F, Bachy E, Salles G, Huynh A, de Latour RP, Labussière-Wallet H, Ader F.

Am J Hematol. 2019 Apr;94(4):E109-E111. doi: 10.1002/ajh.25406. Epub 2019 Feb 4. No abstract available.

PMID:
30663089

Supplemental Content

Loading ...
Support Center